| 2025 |
A Single-Cell RNA-Seq Dataset of Peripheral Blood Cells in Long COVID Patients on Herbal Therapy |
| 2024 |
Anticoronavirus activity of Rhizome of Dryopteris crassirhizoma via multistage targeting of virus entry and viral proteases, Mpro and PLpro |
| 2023 |
Cardamonin as a p38 MAPK signaling pathway activator in-hibits human coronavirus OC43 infection in human lung cells |
| 2023 |
Auraptene has antiviral activity against Human Coronavirus OC43 in MRC-5 cells |
| 2022 |
Natural Polyphenols, 1,2,3,4,6-O-Pentagalloyglucose and Proanthocyanidins, as Broad-Spectrum Anticoronaviral Inhibitors Targeting Mpro and RdRp of SARS-CoV-2 |
| 2022 |
Herbal Medicines for Post-Acute Sequelae (Fatigue or Cogni-tive Dysfunction) of SARS-CoV-2 Infection: A Phase 2 Pilot Clinical Study Protocol |
| 2022 |
Anti-coronaviral Activity of the Natural Phloroglucinols, Dryocrassin ABBA and Filixic acid ABA from the Rhizome of Dryopteris crassirhizoma by Targeting the Main Protease of SARS-CoV-2 |
| 2021 |
Lycorine, a non-nucleoside RNA dependent RNA polymerase inhibitor, as potential treatment for emerging coronavirus infections |
| 2021 |
SARS-CoV-2 RdRp Inhibitors Selected from a Cell-based SARS-CoV-2 RdRp Activity Assay System |
| 2021 |
Broad spectrum antiviral properties of cardiotonic steroids used as potential therapeutics for emerging coronavirus infections |
| 2021 |
Bavachin produces immunoadjuvant activity by targeting the NFAT signaling pathway |
| 2020 |
Infection and activation of B cells by Theiler's Murine Encephalomyelitis Virus (TMEV) leads to autoantibody production in an infectious model of multiple sclerosis |
| 2020 |
A cell-based reporter assay for screening inhibitors of MERS coronavirus RNA-dependent RNA polymerase activity |
| 2020 |
Identification of 4-Anilino-6-aminoquinazoline Derivatives as Potential MERS-CoV Inhibitors |
| 2020 |
ENDOTHELIN-1 CONTRIBUTES TO THE DEVELOPMENT OF VIRUS-INDUCED DEMYELINATING DISEASE |
| 2020 |
Discovery of cyclic sulfonamide derivatives as potent inhibitors of SARS-CoV-2 |
| 2020 |
Kurarinone inhibits HCoV-OC43 infection by impairing the virus-induced autophagic flux in MRC-5 human lung cells |
| 2019 |
Toosendanin from Melia Fructus Suppresses Influenza A Virus infection by Altering Nuclear Localization of Viral Polymerase PA Protein |
| 2019 |
Synthesis and biological evaluation of 3-acyl-2-phenylamino-1,4-dihydroquinolin-4(1H)-one derivatives as potential MERS-CoV inhibitors |
| 2019 |
Natural bis-benzylisoquinoline alkaloids - tetrandrine, fangchinoline, and cepharanthine, inhibit human coronavirus OC43 infection of MRC-5 human lung cells |
| 2018 |
Effects of Keratinocyte-Derived Cytokine (CXCL-1) on the Development of Theiler's Virus-Induced Demyelinating Disease |
| 2017 |
Protective Effect of Panax notoginseng Root Water Extract against Influenza A Virus Infection by Enhancing Antiviral Interferon-Mediated Immune Responses and Natural Killer Cell Activity |
| 2017 |
Ethanolic Extract of Melia Fructus Has Anti-influenza A Virus Activity by Affecting Viral Entry and Viral RNA Polymerase |
| 2017 |
Prostaglandin E2 produced following infection with Theiler's virus promotes the pathogenesis of demyelinating disease |
| 2016 |
In vitro Anti-viral Activity of Psoraleae Semen Water Extract against Influenza A Viruses |
